Promoter hyper-methylation has been reported to result in repression of CAR expression, which induced the down-regulation of the CYP2C19 gene, in human non-cancerous liver and human hepatoma cell lines [32]. Here, CYP2C19 is linked to hepatocellular carcinoma.